CD7 and acute lymphoblastic leukemia: In agreement with our in vitro results (Fig 3E and F), CD7+GFP− leukaemic blasts showed a growth advantage over CD7+GFP+ cells in several animals injected with shIL-18Rα T-ALL cells compared to control mice (Fig 4C).